Viridian Therapeutics Announces Presentations at the American Thyroid Association 91st Annual Meeting - Viridian Therapeutics (NASDAQ:VRDN) - Press Release

- Three late-breaking presentations to feature emerging evidence of VRDN-001 efficacy and differentiation -- VRDN-001 10mg/kg proof of concept data fr

Related Keywords

Montreal ,Quebec ,Canada ,Waltham ,Massachusetts ,United States ,American ,John Jordan ,Exchange Commission ,Company Annual Report On Form ,Neither The Company ,Meeting Of The American Thyroid Association ,Corporate Communications ,Viridian Therapeutics Inc ,Thyroid Eye Disease ,Viridian Therapeutics ,Annual Meeting ,American Thyroid Association ,Jonathan Violin ,Viridian Therapeutic President ,Highlighted Poster Session Details ,Breaking Poster Session Details ,Private Securities Litigation Reform Act ,Annual Report ,Media Contact ,Investor Relations ,